Northwire Canada EditionSunday, October 18, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 108
  1. Nov 05, 2025 · 07:16 · APLI

    Appili Therapeutics Announces Proposed Non-Brokered Private Placement

    Appili Therapeutics Announces Proposed Non-Brokered Private Placement

    01
  2. Nov 05, 2025 · 07:00 · MBX

    Microbix Addresses Cybersecurity Incident

    Microbix Addresses Cybersecurity Incident

    02
  3. Nov 05, 2025 · 03:52 · NARA

    Pangenomic enters LOI for distribution deal with Ayla

    Pangenomic enters LOI for distribution deal with Ayla

    03
  4. Nov 04, 2025 · 23:53 · EPRX

    Eupraxia ends Q3 with cash of $89-million (U.S.)

    Eupraxia ends Q3 with cash of $89-million (U.S.)

    04
  5. Nov 04, 2025 · 23:20 · HEM

    Hemostemix closes $461,230 first tranche of financing

    Hemostemix closes $461,230 first tranche of financing

    05
  6. Nov 04, 2025 · 20:00 · NARA

    PanGenomic Health Signs Letter of Intent with Ayla BioScience

    PanGenomic Health Signs Letter of Intent with Ayla BioScience

    06
  7. Nov 04, 2025 · 18:01 · MYTC

    MyndTec Inc. Completes Seventh Tranche of Non-Brokered Private Placement

    MyndTec Inc. Completes Seventh Tranche of Non-Brokered Private Placement

    07
  8. Nov 04, 2025 · 17:50 · IOT

    Innovotech Inc. Reports Record Revenue For Its Third Quarter.

    Innovotech Inc. Reports Record Revenue For Its Third Quarter.

    08
  9. Nov 04, 2025 · 16:53 · KNE

    Kane receives clinical, preclinical data for revyve

    Kane receives clinical, preclinical data for revyve

    09
  10. Nov 04, 2025 · 16:39 · EPRX

    Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results

    Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results

    10
  11. Nov 04, 2025 · 15:10 · HEM

    Hemostemix Closes Private Placement of $461,230

    Hemostemix Closes Private Placement of $461,230

    11
  12. Nov 04, 2025 · 11:51 · BNXT

    Bionxt receives EU patent grant notice for oral MS film

    Bionxt receives EU patent grant notice for oral MS film

    12
  13. Nov 04, 2025 · 09:01 · TTI

    Thiogenesis Reports Positive Interim Phase 2 Trial Results for MELAS and Announces Pipeline Advancements in Leigh Syndrome and Cystinosis

    Thiogenesis Reports Positive Interim Phase 2 Trial Results for MELAS and Announces Pipeline Advancements in Leigh Syndrome and Cystinosis

    13
  14. Nov 04, 2025 · 07:30 · BCT

    BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+(TM) in Breast and Prostate Cancer Models

    BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+(TM) in Breast and Prostate Cancer Models

    14
← Newer Older →